300 top medical experts on Adenocarcinoma in Situ across 33 countries and 25 U.S. states, including 187 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Adenocarcinoma in Situ: A lesion with cytological characteristics associated with invasive adenocarcinoma but the tumor cells are confined to the glandular epithelial cells of origin. Adenocarcinoma in situ of the cervix and the lung are the most common.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Adenocarcinoma (5,212), Carcinoma in Situ (3,143).
  4. Clinical Trials ClinicalTrials.gov : at least 12 including 1 Active, 5 Completed, 4 Recruiting


  

        

                    


    Computing Expert Listing ...

);